会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • IDENTIFICATION AND CHARACTERIZATION OF HCV REPLICON VARIANTS WITH REDUCED SUSCEPTIBILITY TO HCV-796, AND METHODS RELATED THERETO
    • 具有降低HCV-796易感性的HCV REPLICON变体的鉴定和表征及其相关方法
    • US20080182895A1
    • 2008-07-31
    • US11842312
    • 2007-08-21
    • Anita Y.M. HoweRajiv Chopra
    • Anita Y.M. HoweRajiv Chopra
    • A61K31/343C12Q1/00A61P31/12
    • G01N33/5767A61K31/343A61K31/7056A61K45/06G01N2333/18A61K2300/00
    • The present invention provides methods of decreasing the frequency of emergence, decreasing the level of resistance, and delaying the emergence of a treatment-resistant Hepatitis C viral infection, by administering to a subject, either in combination or in series, an inhibitor of the Hepatitis C RNA-dependent RNA polymerase NS5B, e.g., a benzofuran, such as 5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-N-methyl-1-benzofuran-3-carboxamide (HCV-796), and at least one additional anti-Hepatitis C agent, e.g., a ribavirin product or an immunomodulator, such as an interferon product. Additionally, the invention relates to methods of monitoring the course of treatment of a Hepatitis C viral infection, methods of monitoring and prognosing a Hepatitis C viral infection, and methods of identifying an individual with a decreased likelihood of responding to an anti-Hepatitis C viral therapy. These methods use the sequence and/or structure of the Hepatitis C RNA-dependent RNA polymerase NS5B to identify the emergence of a treatment-resistant Hepatitis C viral infection, particularly a benzofuran (e.g., HCV-796) treatment-resistant Hepatitis C viral infection.
    • 本发明提供降低出血频率,降低耐药水平并延缓出现治疗抗性丙型肝炎病毒感染的方法,通过给予受试者,组合或串联地将肝炎抑制剂 C RNA依赖性RNA聚合酶NS5B,例如苯并呋喃,如5-环丙基-2-(4-氟苯基)-6 - [(2-羟乙基)(甲基磺酰基)氨基] -N-甲基-1-苯并呋喃-3 (HCV-796)和至少一种另外的抗丙型肝炎药物,例如利巴韦林产品或免疫调节剂,例如干扰素产物。 此外,本发明涉及监测丙型肝炎病毒感染的治疗过程,监测和预测丙型肝炎病毒感染的方法的方法,以及鉴定具有降低的抗丙型肝炎病毒反应可能性的个体的方法 治疗。 这些方法使用丙型肝炎病毒RNA依赖性RNA聚合酶NS5B的序列和/或结构来鉴定治疗抗性丙型肝炎病毒感染,特别是苯并呋喃(例如HCV-796)治疗抗性丙型肝炎病毒感染的出现 。